NewAmsterdam Pharma Company
NAMS
#3710
Rank
S$4.38 B
Marketcap
S$38.17
Share price
-4.88%
Change (1 day)
22.65%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2025 (TTM): -S$0.37 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are S$35.24 Million. In 2024 the company made an earning of -S$0.32 Billion a decrease over its 2023 earnings that were of -S$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2023 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.37 Billion15.16%
2024 -S$0.32 Billion38.38%
2023 -S$0.23 Billion